Tony Ye is the Co-Founder and Managing Partner of LYZZ Capital. He is familiar with all aspects of drug research and development and sales, and has rich experience in pharmaceutical sales and government affairs. Before co-founding LYZZ Capital, he was a Founding Partner of Jianxin Capital and Jianxin Venture Healthcare Fund. Prior to that, he was the Director of Government Affairs, Assistant President and Vice President of Marketing of the Antibiotics Division of Shanghai Pharma Group, where he was in charge of the Group's Government Affairs. He was the National Government Affairs Director of Aventis Pharmaceuticals and the Regional Sales Manager and National Government Affairs Manager of Bayer (China). Tony invested in a number of biomedical companies, including of Newmed Medical, Beijing Lida Kang Technology, Suzhou Bright-Gene Pharma, Shanxi Kanghui Pharma, Wuhan Hiteck Pharma, Zhejiang AngLiKang Pharma, among others.
Tony received a Bachelor's degree of pharmaceutical chemistry from Shanghai Medical University and an EMBA degree from China Europe International Business School.